Investors hammered Cooper Companies (COO) on Thursday after the medtech's fiscal third-quarter sales lagged Wall Street's expectations, leading to a guidance cut. Specifically, the CooperVision segment — which sells contact lenses — missed expectations by 4.5%, William Blair analyst Steven Lichtman said in a report. The miss was due to destocking. Further, the company opted against selling its CooperSurgical business…